Propeller Health acquired by ResMed for $225M

A Wisconsin-based startup that makes digital inhalers has been purchased by medical device giant ResMed for $225 million. Propeller Health, which bills itself as the “leading digital therapeutics company” created a digital inhaler to help patients with chronic obstructive pulmonary disease (COPD), a disease that impacts 16 million Americans. ResMed CEO Mick Farrell called the purchase a “significant step for ResMed towards becoming the global leader in digital health for COPD.” ResMed has manufactured more than 6 million cloud-connected remote monitoring devices, with a focus on sleep apnea and respiratory illnesses.